Viewing Study NCT05662202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-07-04 @ 12:07 AM
Study NCT ID: NCT05662202
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-08
First Post: 2022-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Sponsor: Biofrontera Bioscience GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Actinic Keratoses View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Actinic keratosis View
None Photodynamic therapy View
None 5-aminolevulinic acid View
None Photosensitizing Agents View